Cushing Syndrome 3
Cushing Syndrome 3
Cushing Syndrome 3
in
Cushing Syndrome
Jason Klein, MD, Patricia Vuguin, MD, MSc, Sharon Hyman, MD
Department of Pediatric Endocrinology, Cohen Children’s Medical Center of New York, New Hyde Park, NY
AUTHOR DISCLOSURE Drs Klein, Vuguin, Cushing syndrome (CS) is a state of glucocorticoid excess in which there is loss of
and Hyman have disclosed no financial
the normal hypothalamic-pituitary-adrenal feedback axis. First described in 1912
relationships relevant to this article. This
commentary does not contain discussion by American neurosurgeon Dr Harvey Williams Cushing in reference to a 23-year-
of unapproved/investigative use of old patient with obesity, hirsutism, and amenorrhea, CS has since been recog-
a commercial product/device.
nized as a rare, yet serious and significant, condition in the pediatric population.
Under normal circumstances, hypothalamic corticotropin-releasing hormone
(CRH) is delivered to the anterior pituitary via the portal circulation, resulting in
adrenocorticotropin hormone (ACTH) release from the anterior pituitary into the
systemic circulation. ACTH acts on the zona fasciculata of the adrenal cortex to
stimulate release of cortisol. The secretion of cortisol results in negative feedback,
downregulating production of both ACTH and CRH. Cortisol has metabolic and
cardiovascular effects. It plays an important role in hepatic glucose metabolism by
increasing gluconeogenesis and glycogenolysis, as well as affecting proteolysis
and lipolysis. In addition, it influences myocardial contractility, cardiac output,
and blood pressure. It also has a variety of effects on the immunologic and
inflammatory systems, musculoskeletal and connective tissue, and fluid and
electrolyte homeostasis, as well as neuropsychiatric, behavioral, gastrointestinal,
and developmental effects. In the general population, there are approximately 2 to
5 new cases per million per year of CS; only approximately 10% of these cases
occur in the pediatric population. Although adolescents with CS, similar to
adults, have a slight female to male predominance, this predilection goes away
in younger patients and may even be reversed in infants with CS.
Pediatric CS can be divided into 2 distinct categories: ACTH dependent and
ACTH independent (Table 1). The most common cause of CS is exogenous
administration of corticosteroids, which have become the first-line treatment of
multiple pediatric disorders. Although oral corticosteroids are generally implicated
in the development of CS, long-term use of inhaled and topical corticosteroids,
commonly used as treatment for asthma and atopic dermatitis, respectively, can also
result in CS. In addition, ACTH, used as treatment in certain seizure disorders, can
stimulate adrenal cortisol release, resulting in CS.
Cushing’s Syndrome in Children and When exogenous causes of CS have been ruled out based on a careful history,
Adolescents: Presentation, Diagnosis, and
endogenous causes should be sought. In children older than 5 years, Cushing
Therapy. Magiakou MA, Mastorakos G,
Oldfield EH, et al. N Engl J Med. 1994;331 disease (hypercortisolism resulting from oversecretion of pituitary ACTH from
(10):629–636 a corticotroph adenoma) is the most common cause of CS. In contrast, infants are
The Diagnosis of Cushing’s Syndrome: An most likely to have a primary adrenal condition, such as an adrenocortical tumor
Endocrine Society Clinical Practice (adenoma or carcinoma). Although adrenocortical tumors are fairly rare in the
Guideline. Nieman LK, Biller BM, Findling JW,
pediatric age group, comprising only approximately 0.6% of childhood tumors,
et al. J Clin Endocrinol Metab. 2008;93
(5):1526–1540 upward of one-third manifest with signs and symptoms of CS. Nearly all are
unilateral (90% to 98%) and more than 70% are malignant. Most unilateral
Cushing Syndrome in Pediatrics. Stratakis
CA. Endocrinol Metab Clin N Am. 2012;41 adrenal tumors are sporadic, but they may be part of a genetic syndrome, such as
(4):793–803 Beckwith-Wiedemann syndrome or Li-Fraumeni syndrome.
Rarer causes of ACTH-independent CS include primary especially elevation of diastolic blood pressure, occurs in
pigmented nodular adrenocortical disease, a condition char- approximately half of pediatric patients with CS.
acterized by bilateral nodular adrenals. Primary pigmented The initial step in making the diagnosis of CS is confirm-
nodular adrenocortical disease is associated with atypical or ing the presence of elevated cortisol levels (hypercortisolism)
cyclical CS and is the most frequent presentation of Carney in 2 separate measurements. Screening tests, particularly
complex in children and adolescents, characterized by skin when in conjunction with each other, have a high sensitivity
pigmentary abnormalities, myxomas, endocrine tumors or and sensitivity for detecting CS. Twenty-four-hour urine
overactivity, and schwannomas. Massive macronodular ad-
renal hyperplasia is rare and associated with extremely large
adrenals and multiple cortisol-producing adenomatous nod-
TABLE 2. Signs and Symptoms of Cushing
ules. McCune-Albright syndrome, a triad of precocious pu-
Syndrome
berty, cafe-au-lait spots, and polyostotic fibrous dysplasia, can
result in continually activated, ACTH-independent cortisol PATIENTS AT
release. SIGN OR SYMPTOM PRESENTATION, %
In ACTH-dependent CS, ectopic ACTH release by cer- Weight gain 90
tain tumors, such as squamous cell carcinoma of the lung
Growth failure 83
and neuroendocrine masses, is an infrequent cause of CS,
Hirsutism or acne 78
representing only approximately 1% of cases of pediatric CS.
The classic signs and symptoms of CS (Table 2) tend to be Amenorrhea and delay puberty 78
insidious in development and are not always all present. By Generalized for centripetal obesity (buffalo 75
far, the most common presentation in pediatrics is growth hump or moon facies)
failure in association with excessive weight gain, present in Osteopenia 70
nearly 90% of cases. Review of growth curves in the pre- Violaceous striae (may be hyperpigmented 60
ceding years is a crucial step in the workup of CS. Because when ACTH level is elevated)
exogenous obesity is associated with tall stature and robust Hypertension 50
growth velocity, evaluation for CS should be considered in
Headaches 25
any patient with poor growth velocity with increased weight
Plethora and skin bruising 25
gain. Hirsutism and acne are common, as well as irregular
menses in adolescent girls. Buffalo hump, from an increased Compulsive behaviors and emotional 20
lability (depression)
dorsocervical fat pad, and/or moon facies may be seen in
three-quarters of patients. Osteopenia tends to be subclinical Muscle weakness 12
and is likely underdiagnosed, although bone mineral density ACTH¼adrenocorticotropin hormone.
is regained after adequate treatment of CS. Hypertension,
Updated Information & including high resolution figures, can be found at:
Services http://pedsinreview.aappublications.org/content/35/9/405
References This article cites 3 articles, 0 of which you can access for free at:
http://pedsinreview.aappublications.org/content/35/9/405.full#ref-list
-1
Subspecialty Collections This article, along with others on similar topics, appears in the
following collection(s):
Endocrinology
http://classic.pedsinreview.aappublications.org/cgi/collection/endocri
nology_sub
Permissions & Licensing Information about reproducing this article in parts (figures, tables) or
in its entirety can be found online at:
https://shop.aap.org/licensing-permissions/
Reprints Information about ordering reprints can be found online:
http://classic.pedsinreview.aappublications.org/content/reprints
The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://pedsinreview.aappublications.org/content/35/9/405
Pediatrics in Review is the official journal of the American Academy of Pediatrics. A monthly
publication, it has been published continuously since 1979. Pediatrics in Review is owned,
published, and trademarked by the American Academy of Pediatrics, 345 Park Avenue, Itasca,
Illinois, 60143. Copyright © 2014 by the American Academy of Pediatrics. All rights reserved.
Print ISSN: 0191-9601.